> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Calcipotriene ANDA Withdrawal Corrected
- URL: https://www.fdaweb.com/calcipotriene-anda-withdrawal-corrected/
- Published: 2023-09-25T12:00:00.000Z
- Updated: 2026-09-14T18:58:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155405

*Federal Register* notice: FDA is correcting a 6/2 notice entitled “Hospira, Inc., et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications.” One of the ANDAs, Tolmar’s ANDA 077029 for calcipotriene solution, is no longer being withdrawn after the company requested its continued approval. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-09-25/pdf/2023-20742.pdf?ref=fdaweb.com).